drugset / Trial / NCT00584779

An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis

NCT00584779

Phase 4 Terminated 8 enrolled Viatris Inc.
NaParallel-groupOpen-labelTreatment

Summary

To confirm the pharmacokinetics following administration of gabapentin to Japanese subjects with renal impairment, compare the results to Western study results and confirm the adaptive possibility of dose adjustment in US package insert to Japanese.

Timeline

Start
2007-10
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule

Indications

No indication recorded.